BRIEF-Alkermes submits supplemental new drug application to FDA By: Reuters: Company News August 08, 2016 at 07:36 AM EDT * Alkermes submits supplemental new drug application to FDA for two month dosing option of Aristada for treatment of schizophrenia Read More >> Related Stocks: Alkermes Plc